Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Ann Work Expo Health ; 67(4): 496-507, 2023 04 21.
Article in English | MEDLINE | ID: mdl-36789550

ABSTRACT

In this study, 129 exposure situations (ESs) with six or more measured inhalation exposures to dust from solids or vapour from liquids in occupational settings were compared with modelled European Centre of Ecotoxicology and Toxicology of Chemicals (ECETOC) targeted risk assessment tool, version 3 (TRAv3) estimates. The measurement data were extracted from previously published studies examining TRAv3 performance and pooled into a curated database. The comparison exercise focussed on the vapour exposure scenarios, as there were too few dust scenarios for a meaningful analysis of any required model corrections. A group of experts in the exposure modelling field retrieved and reviewed the input parameters used in these ESs. Where considered appropriate, modifications were applied to better match the input parameter definitions and the scope of applicability of the TRAv3. Differences and mean absolute error (MAE) were calculated between the log-transformed modelled exposure value and the 75th percentile of each measured data set and regression analysis was performed. The results indicated that the TRAv3 overestimated 80% of the measured data sets. Both over- and underestimations were mostly by factors 1-5. The calculated MAE for liquids was 0.7, indicating that on average the difference between the 75th percentile and the TRAv3 estimate was less than one order of magnitude. A multiple linear regression showed that some input parameters such as medium volatility, certain process categories (PROC), industrial setting, and the presence of local exhaust ventilation are associated with underestimations. The results of the regression analysis can be used by TRAv3 users to review the degree of over- or underestimation in their current exposure assessments, compared to the curated database. Although multiple linear regression is an appropriate methodology to characterize the TRAv3's performance, more data sets are still needed in view of some remaining data gaps. Nevertheless, the results of the current analysis are being used by ECETOC to further develop the tool as a suitably conservative screening tool for use in REACH chemical safety assessment of occupational exposure to chemicals.


Subject(s)
Occupational Exposure , Humans , Occupational Exposure/analysis , Ecotoxicology , Inhalation Exposure/analysis , Regression Analysis , Risk Assessment/methods , Dust
2.
J Expo Sci Environ Epidemiol ; 33(6): 980-993, 2023 Nov.
Article in English | MEDLINE | ID: mdl-36681733

ABSTRACT

BACKGROUND: The European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) Targeted Risk Assessment (TRA) Consumer tool was developed to fill in a methodology gap for a high throughput, screening level tool to support industry compliance with the European Union's Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) regulation. OBJECTIVE: To evaluate if the TRA Consumer tool has met its design of being a screening level tool (i.e., one which does not under-predict potential exposures). METHODS: The TRA Consumer tool algorithms and defaults were reviewed and performance benchmarked vs. other consumer models and/or empirical data. Findings from existing reviews of the TRA consumer tool were also considered and addressed. RESULTS: TRA predictions based on its default inputs exceeded measured exposures when available, typically by orders of magnitude, and were generally greater than or similar to those of other consumer exposure tools. For dermal exposure from articles, there was no evidence that a diffusivity approach would provide more appropriate exposure estimates than those of the TRA. When default values are refined using more specific data, the refined values must be considered holistically to reflect the situation being modeled as some parameters may be correlated. SIGNIFICANCE: This is the first evaluation of the ECETOC TRA consumer tool in its entirety, considering algorithms, input defaults, and associated predictions for consumer products and articles. The evaluation confirmed its design as a screening level tool. IMPACT STATEMENT: The ECETOC TRA Consumer tool has been widely applied to generate exposure estimates to support chemical registrations under the EU REACH regulation. This evaluation supports the appropriateness of the TRA as a screening level exposure assessment tool. It also warrants additional measurements of consumer exposure, especially for article use scenarios, to aid the development of consumer exposure tools and chemical risk assessment.


Subject(s)
Ecotoxicology , Occupational Exposure , Humans , Occupational Exposure/analysis , Algorithms , Risk Assessment/methods , Industry
3.
Article in English | MEDLINE | ID: mdl-33202685

ABSTRACT

(1) Background: The ECETOC Targeted Risk Assessment (TRA) tool is widely used for estimation of worker exposure levels in the development of dossiers for REACH registration of manufactured or imported chemical substances in Europe. A number of studies have been published since 2010 in which the exposure estimates of the tool are compared with workplace exposure measurement results and in some instances an underestimation of exposure was reported. The quality and results of these studies are being reviewed by ECETOC. (2) Methods: Original exposure measurement data from published comparison studies for which six or more data points were available for each workplace scenario and a TRA estimate had been developed to create a curated database to examine under what conditions and for which applications the tool is valid or may need adaptation. (3) Results: The published studies have been reviewed for completeness and clarity and TRA estimates have been constructed based on the available information, following a set of rules. The full review findings are expected to be available in the course of 2021. (4) Conclusions: The ECETOC TRA tool developers periodically review the validity and limitations of their tool, in line with international recommendations.


Subject(s)
Occupational Exposure , Environmental Exposure/adverse effects , Europe , Risk Assessment/methods
4.
Environ Sci Process Impacts ; 20(1): 12-19, 2018 Jan 24.
Article in English | MEDLINE | ID: mdl-29140392

ABSTRACT

The process for undertaking exposure assessments varies dependent on its purpose. But for exposure assessments to be relevant and accurate, they are reliant on access to reliable information on key exposure determinants. Acquiring such information is seldom straightforward and can take significant time and resources. This articles examines how the application of tiered and targeted approaches to information acquisition, within the context of European human health risk assessments, can not only lead to improvements in the efficiency and effectiveness of the process but also in the confidence of stakeholders in its outputs. The article explores how the benefits might be further improved through the coordination of such activities, as well as those areas that represent barriers to wider international harmonisation.


Subject(s)
Environmental Exposure/analysis , Hazardous Substances/analysis , Risk Assessment/methods , Europe , Humans , International Cooperation , Risk Assessment/legislation & jurisprudence
5.
Environ Sci Process Impacts ; 16(5): 970-7, 2014 May.
Article in English | MEDLINE | ID: mdl-24638261

ABSTRACT

The ECETOC Targeted Risk Assessment (TRA) model is intended to evaluate the nature of human and environmental exposures and risks arising from the manufacture and use of chemicals and version 2 has been extensively applied to develop Chemical Safety Assessments for substances registered under Phase 1 of REACH. In order to maintain the model, ECETOC solicited suggestions from TRA users arising from their experiences gained from its use in the 2009-2011 period. TRA users identified 16 different ways in which the worker exposure predictions of the TRA might be further improved at the technical level. The suggestions can be divided into those that are capable of being incorporated into the model and those which cannot which, in turn, appear to be reflective of the wide range of technical understandings of users of Tier 1 REACH models such as the TRA. The consequence of such user heterogeneity presents challenges for model developers, particularly those models intended for inclusion in regulatory processes. Those considerations that are relevant for the revision to the worker portion of the TRA (version 3) are described, together with their potential relevance for other REACH exposure models.


Subject(s)
Environmental Exposure/analysis , Environmental Monitoring/methods , Models, Chemical , Environmental Exposure/statistics & numerical data , Environmental Pollutants/analysis , Environmental Pollution/statistics & numerical data , Humans , Risk Assessment/methods
6.
J Expo Sci Environ Epidemiol ; 24(1): 27-35, 2014.
Article in English | MEDLINE | ID: mdl-23361440

ABSTRACT

The European Solvents Industry Group (ESIG) Generic Exposure Scenario (GES) Risk and Exposure Tool (EGRET) was developed to facilitate the safety evaluation of consumer uses of solvents, as required by the European Union Registration, Evaluation and Authorization of Chemicals (REACH) Regulation. This exposure-based risk assessment tool provides estimates of both exposure and risk characterization ratios for consumer uses. It builds upon the consumer portion of the European Center for Ecotoxicology and Toxicology of Chemicals (ECETOC) Targeted Risk Assessment (TRA) tool by implementing refinements described in ECETOC TR107. Technical enhancements included the use of additional data to refine scenario defaults and the ability to include additional parameters in exposure calculations. Scenarios were also added to cover all frequently encountered consumer uses of solvents. The TRA tool structure was modified to automatically determine conditions necessary for safe use. EGRET reports results using specific standard phrases in a format consistent with REACH exposure scenario guidance, in order that the outputs can be readily assimilated within safety data sheets and similar information technology systems. Evaluation of tool predictions for a range of commonly encountered consumer uses of solvents found it provides reasonable yet still conservative exposure estimates.


Subject(s)
Environmental Monitoring/methods , Industry/standards , Occupational Exposure , Risk Assessment/methods , Solvents/analysis , Toxicology/methods , Algorithms , Consumer Product Safety/standards , European Union , Humans , Maximum Allowable Concentration , Solvents/standards
7.
Regul Toxicol Pharmacol ; 66(2): 241-7, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23579077

ABSTRACT

An approach is described for how the quality of human data can be systematically assessed and categorised. The approach mirrors the animal data quality considerations set out by Klimisch et al., in order that human data quality can be addressed in a complementary manner and to help facilitate transparent (and repeatable) weight of evidence comparisons. Definitions are proposed for the quality and adequacy of data. Quality is differentiated into four categories. A description of how the scheme can be used for evaluating data reliability, especially for use when contributing entries to the IUCLID database, is shown. A discussion of how the criteria might also be used when determining overall data relevance is included. The approach is intended to help harmonise human data evaluation processes worldwide.


Subject(s)
Research Design/standards , Animals , Clinical Trials as Topic/standards , Epidemiologic Studies , Human Experimentation/standards , Humans , Risk Assessment/standards
8.
Ann Occup Hyg ; 57(3): 280-5, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23482456

ABSTRACT

The British Occupational Hygiene Society, in collaboration with the Institute of Occupational Medicine, the University of Manchester, the UK Health and Safety Executive, and the University of Aberdeen hosted the 7th International Conference on the Science of Exposure Assessment (X2012) on 2 July-5 July 2012 in Edinburgh, UK. The conference ended with a special session at which invited speakers from government, industry, independent research institutes, and academia were asked to reflect on the conference and discuss what may now constitute the important highlights or drivers of future exposure assessment research. This article summarizes these discussions with respect to current and future technical and methodological developments. For the exposure science community to continue to have an impact in protecting public health, additional efforts need to be made to improve partnerships and cross-disciplinary collaborations, although it is equally important to ensure that the traditional occupational exposure themes are still covered as these issues are becoming increasingly important in the developing world. To facilitate this the 'X' conferences should continue to retain a holistic approach to occupational and non-occupational exposures and should actively pursue collaborations with other disciplines and professional organizations to increase the presence of consumer and environmental exposure scientists.


Subject(s)
Disaster Planning/methods , Nanostructures/analysis , Occupational Exposure/analysis , Developing Countries , Humans , Inventions , Methods , Occupational Health/legislation & jurisprudence , Occupational Medicine
9.
Regul Toxicol Pharmacol ; 62(2): 302-12, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22119668

ABSTRACT

Although regulatory agencies formally encourage the integration of all available data in chemical risk assessment, consistent implementation of this practice has been constrained by the lack of a clear, systematic method for doing so. In this paper, we describe a methodology for evaluating, classifying and integrating human and animal data into the risk assessment process that incorporates: (1) a balanced appraisal of human and animal data, (2) relevance to different stages of the risk assessment process, and (3) accommodation for different data quality requirements. The proposed framework offers a flexible, step-wise approach for determining which set of available data best support the chemical risk assessment that involves the rating and relative ranking of human and animal data quality. The evaluation of human data incorporates seven data quality elements, nature and specificity of the lead effect; evaluation of animal data incorporates data quality and relevance to humans. Results of simulations with selected chemicals previously evaluated in a formal risk assessment generally agreed with existing regulatory guidance. Application of the proposed framework across a wider range of chemical agents will improve transparency of the risk assessment process and validity of results, while informing continuous refinements to this evolving methodology.


Subject(s)
Risk Assessment , Animals , Humans , Statistics as Topic
10.
Ann Occup Hyg ; 55(5): 451-64, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21551289

ABSTRACT

The European Union Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) Regulation (EC 1907/2006) places significant new obligations on the manufacturers or importers (M/Is) of chemicals in Europe. It also places new responsibilities on downstream users (DUs) of these chemicals i.e. those that purchase and use chemical products. In particular, for registered classified substances, the M/I is expected to communicate how any substance can be safely used without risk to man or the environment. This communication is in the form of an exposure scenario (ES), which is included in an Annex to the REACH extended safety data sheet. DUs then have certain obligations relating to adopting the control conditions described in the ES. The REACH Technical Guidance Documents lay down the expectations for the process of risk assessment that M/Is should adopt when developing ESs. But with many thousands of chemicals in daily commerce, it is also necessary to ensure that what is communicated to DUs not only meets the requirements of REACH but is also understandable to these groups, as well as being consistent across different chemical suppliers and supply chains. In cooperation with relevant DU groups, the European solvents industry has developed generic approaches for describing how solvents are commonly used, in order that these can subsequently be used as the basis for REACH registrations and related safety data sheet communications on health risk control. The utility of these approaches (termed 'generic exposure scenarios') is acknowledged under REACH and they are now publicly available for use both by M/Is and DUs.


Subject(s)
Chemical Industry/legislation & jurisprudence , Occupational Exposure/prevention & control , Risk Assessment/methods , Risk Management/methods , Environmental Monitoring , European Union , Humans , Models, Theoretical , Occupational Exposure/legislation & jurisprudence , Registries , Safety
11.
Environ Health ; 7 Suppl 1: S12, 2008 Jun 05.
Article in English | MEDLINE | ID: mdl-18541066

ABSTRACT

Biomonitoring, the determination of chemical substances in human body fluids or tissues, is more and more frequently applied. At the same time detection limits are decreasing steadily. As a consequence, many data with potential relevance for public health are generated although they need not necessarily allow interpretation in term of health relevance. The European Centre of Ecotoxicology and Toxicology of Chemicals (ECETOC) formed a dedicated task force to build a framework for the interpretation of biomonitoring data. The framework that was developed evaluates biomonitoring data based on their analytical integrity, their ability to describe dose (toxicokinetics), their ability to relate to effects, and an overall evaluation and weight of evidence analysis. This framework was subsequently evaluated with a number of case studies and was shown to provide a rational basis to advance discussions on human biomonitoring allowing better use and application of this type of data in human health risk assessment.


Subject(s)
Environmental Monitoring , Humans , Risk Assessment
12.
J Expo Sci Environ Epidemiol ; 17 Suppl 1: S16-25, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17851448

ABSTRACT

The new European chemicals legislation REACH (Registration, Evaluation, Authorisation and restriction of Chemicals) requires the development of Exposure Scenarios describing the conditions and risk management measures needed for the safe use of chemicals. Such Exposure Scenarios should integrate considerations of both human health and the environment. Specific aspects are relevant for worker exposure. Gathering information on the uses of the chemical is an important step in developing an Exposure Scenario. In-house information at manufacturers is an important source. Downstream users can contribute information through direct contact or through their associations. Relatively simple approaches (Tier 1 tools, such as the ECETOC Targeted Risk Assessment and the model EASE) can be used to develop broad Exposure Scenarios that cover many use situations. These approaches rely on the categorisation of just a few determinants, including only a small number of risk management measures. Such approaches have a limited discriminatory power and are rather conservative. When the hazard of the substance or the complexity of the exposure situation require a more in-depth approach, further development of the Exposure Scenarios with Tier 2 approaches is needed. Measured data sets of worker exposure are very valuable in a Tier 2 approach. Some downstream user associations have attempted to build Exposure Scenarios based on measured data sets. Generic Tier 2 tools for developing Exposure Scenarios do not exist yet. To enable efficient development of the worker exposure part of Exposure Scenarios a further development of Tier 1 and Tier 2 tools is needed. Special attention should be given to user friendliness and to the validity (boundaries) of the approaches. The development of standard worker exposure descriptions or full Exposure Scenarios by downstream user branches in cooperation with manufacturers and importers is recommended.


Subject(s)
Chemical Industry/legislation & jurisprudence , Occupational Exposure/prevention & control , Safety Management/methods , Cluster Analysis , Environmental Monitoring , European Union , Humans , Models, Theoretical , Occupational Exposure/legislation & jurisprudence , Risk Assessment/methods , Risk Management/legislation & jurisprudence , Risk Management/methods , Safety Management/legislation & jurisprudence
13.
J Expo Sci Environ Epidemiol ; 17(4): 308-13, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17495868

ABSTRACT

The ability to measure chemicals in humans (often termed biomonitoring) is far outpacing the ability to interpret reliably these data for public health purposes, creating a major knowledge gap. Until this gap is filled, the great promise of routinely using biomonitoring data to support decisions to protect public health cannot be realized. Research is needed to link biomonitoring data quantitatively to the potential for adverse health risks, either through association with health outcomes or using information on the concentration and duration of exposure, which can then be linked to health guidelines. Developing such linkages in the risk assessment paradigm is one of the primary goals of the International Council of Chemical Associations' (ICCA) Long-Range Research Initiative (LRI) program in the area of biomonitoring. Therefore, ICCA sponsored a workshop to facilitate development of a coordinated agenda for research to enable an improved interpretation of human biomonitoring data. Discussions addressed three main topics: (1) exploration of the link between exposure, dose, and human biomonitoring data, (2) the use of computational tools to interpret biomonitoring data, and (3) the relevance of human biomonitoring data to the design of toxicological studies. Several overarching themes emerged from the workshop: (a) Interpretation and use of biomonitoring data should involve collaboration across all sectors (i.e., industry, government, and academia) and countries. (b) Biomonitoring is not a stand-alone tool, and it should be linked to exposure and toxicological dose information. (c) Effective communication is critical, because when uncertainty about the actual risks is high, the perceived risks grow in the absence of communication. (d) The scope of future biomonitoring activities encompasses a variety of research approaches - from advancing the science to fill data gaps to advancing the accessibility of the current knowledge to enable better information sharing.


Subject(s)
Data Interpretation, Statistical , Environmental Monitoring/methods , Animals , Biomarkers/blood , Biomarkers/urine , Humans , Public Health , Risk Assessment , Toxicity Tests
14.
J Expo Sci Environ Epidemiol ; 17 Suppl 1: S34-7, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17495870

ABSTRACT

The primary process established by the European Commission to address the science needed to define key REACH concepts and to help rationally implement REACH's ambitions is enshrined in a series of activities known as the REACH Implementation Projects (RIPs). These are projects that aim to define the methodology that could be used, and present the basis for guidance on the actual principles and procedures that may be (are proposed to be) followed in the development of the required documentation that ensures the safe use of chemicals. In order to develop soundly based and equitable regulation, it is necessary that science governance using established and accepted scientific principles must take a leading role. The extent to which such governance is embraced will be determined by many factors, but notably the process adopted to enable scientific discussion to take place. This article addresses the issues of science as they have impacted on the exemplification of the Exposure Scenario concept under REACH. The current RIP activities have created a non-adversarial process in which the key stakeholders are able to discuss the key REACH challenges. But the RIP activities will be finalised before REACH comes into force. A suitable mechanism should perhaps now be identified to ensure that this positive spirit of scientific discussion and collaboration can continue to benefit REACH and those that it serves well into the future.


Subject(s)
Chemical Industry , Environmental Exposure , Government Regulation , Public Policy , Science/methods , Chemical Industry/legislation & jurisprudence , Environmental Exposure/legislation & jurisprudence , Environmental Exposure/prevention & control , Environmental Monitoring , European Union , Humans
15.
Risk Anal ; 27(2): 387-96, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17511705

ABSTRACT

The incorporation of human experience data (HD) into the risk assessment process is encouraged by various authorities with the aim of improving the robustness of the subsequent findings. HD, however, can present in many forms, ranging from epidemiological studies to the accumulated experiences from poison centers. This diversity of the human experience, combined with the manner in which it may (or may not) present, creates several challenges for risk assessors if they are to give available HD due weight in the RA process. An evaluation was made of how HD has been cited and used within the 64 human health RAs published by the EU to the end of 2005. In all RAs, HD had been cited to some degree. But there was no consistency between how cited data had subsequently been taken forward and used in the evaluation of different endpoints, either between the RAs authored by the same or different EU Member States. The lack of any accepted guidance for addressing the role that HD can play within the RA process appears to lead to this situation. Recommendations are provided on the scope and focus such guidance could usefully be expected to take.


Subject(s)
Epidemiologic Methods , Poisoning/epidemiology , Risk Assessment , Animals , Environmental Exposure , European Union , Humans , Poisons/toxicity , Risk Management/methods
16.
J Expo Sci Environ Epidemiol ; 17 Suppl 1: S67-71, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17457324

ABSTRACT

ECETOC has been developed an approach by which the health and environmental risks arising from the supply and use of chemicals can be quickly and reliably evaluated by chemical suppliers. The approach has been available as a web-based tool since 2004. During the development and implementation of the approach, ECETOC has consulted widely so that the approach is seen to meet the required levels of science while also meeting the differing needs of affected stakeholders. The consultation process has yielded a number of findings in terms of the considerations necessary for implementing successful risk-informed decision-making in a multi-stakeholder environment. Concurrently, as the European Commission's REACH legislative package has begun to take shape, it has also become apparent that the approach has a number of potential applications for aiding the process of risk assessment under REACH. This paper reviews these experiences within the broader context of the expectations that REACH places on chemical manufacturers and suppliers. In particular, it highlights the key role that REACH Exposure Scenarios have for evaluating, managing and communicating chemical risks.


Subject(s)
Environmental Exposure/prevention & control , Risk Assessment/methods , Chemical Industry/legislation & jurisprudence , Decision Making , European Union , Humans , Internet , User-Computer Interface
SELECTION OF CITATIONS
SEARCH DETAIL
...